Lisa Wipperman Heine currently serves on the Board of Directors for several public and early stage, private medtech/biotech companies. In addition, she has held executive leadership roles in both large Medtech companies as well as venture backed start-ups. Most recently, Lisa was President and Chief Executive Officer at preCARDIA, Inc., an early stage, heart failure focused Medtech company which was acquired by Abiomed, Inc. in 2021. Ms. Heine also previously served in multiple leadership roles at ev3 and Covidien, Inc., including Global Vice President of Medical Affairs for Vascular Therapies. During her tenure at Covidien, she helped drive the strategy in support of a $1.7B business and was also responsible for leading the strategy and operations of Clinical Affairs, Healthcare Economics, Policy and Reimbursement and Medical Education functions.

Lisa’s current roles include serving as an independent director for Surmodics, Inc. (NASDAQ: SRDX), Miromatrix (NASDAQ: MIRO) and Gradient Denervation Technologies. She also previously served on the board of Natus Medical (NASDAQ: NTUS) which was acquired by the Archimed Group in 2022.